Skip to main content

Table 1 Clinical characteristics of CRC in different sites in the SEER database

From: Analysis of prognosis, genome, microbiome, and microbial metabolome in different sites of colorectal cancer

 

Cecum

Ascending colon

Transverse colon

Descending colon

Sigmoid colon

Rectum

Total

Median age (min–max)

71 (15–105)

71 (15–108)

70 (13–102)

65 (16-101)

64 (11–106)

61 (14–103)

67 (11–108)

Gender (%)

 Male

9.93

8.81

4.25

3.01

13.81

10.76

50.57

 Female

12.62

10.48

4.54

2.62

11.95

7.22

49.43

Race (%)

 White

18.29

15.38

6.97

4.11

20.04

14.67

79.46

 Black

2.92

2.47

1.13

0.89

2.67

1.43

11.51

 Asian

1.09

1.19

0.56

0.55

2.61

1.57

7.57

 Other

0.25

0.25

0.13

0.08

0.45

0.31

1.46

Stage at presentation (%)

 Stage 0

0.28

0.25

0.08

0.06

0.29

0.15

1.11

 Stage I

4.69

4.25

1.72

1.03

6.02

4.18

21.90

 Stage II

6.73

6.69

3.25

1.84

7.11

4.71

30.32

 Stage III

7.23

5.77

2.53

1.87

8.39

7.27

33.06

 Stage IV

3.61

2.33

1.20

0.83

3.95

1.67

13.60

Histologic subtype (%)

 Adenocarcinoma

19.23

16.54

7.73

5.13

24.21

16.70

89.54

 Mucinous adenocarcinoma

2.59

2.20

0.88

0.42

1.30

0.97

8.37

 Other

0.73

0.55

0.18

0.08

0.25

0.31

2.10

Histologic grade (%)

 Well differentiated

1.92

1.66

0.74

0.50

2.34

1.38

8.54

 Moderately differentiated

14.89

12.73

6.01

4.17

19.75

13.85

71.40

 Poorly differentiated

4.88

4.20

1.77

0.85

3.25

2.47

17.43

 Undifferentiated

0.85

0.69

0.27

0.12

0.43

0.27

2.63

Adequate lymph node examination (more than 12 nodes) (%)

 Yes

18.68

16.59

6.67

4.20

18.47

11.95

76.56

 No

3.81

2.66

2.10

1.43

7.23

5.93

23.17

 Missing data

0.06

0.04

0.02

0.01

0.06

0.09

0.27

Type of surgery (%)

 Local excision

0.02

0.03

0.01

0.02

0.11

0.26

0.45

 Partial colectomy

3.59

2.79

3.54

1.91

20.36

12.41

44.60

 Hemicolectomy

18.39

16.05

4.90

3.48

4.24

0.72

47.77

 Total colectomy

0.29

0.22

0.19

0.15

0.51

3.69

5.04

 Other colectomy

0.24

0.18

0.14

0.08

0.52

0.79

1.94

 No surgery

0.02

0.02

0.01

0.01

0.03

0.12

0.19

Chemotherapy (%)

 Yes

7.33

5.52

2.74

2.14

9.93

12.41

40.07

 No/unknown

15.21

13.77

6.05

3.49

15.83

5.57

59.93

Radiation therapy (%)

 Yes

0.32

0.15

0.06

0.07

0.81

11.38

12.79

 No/unknown

22.23

19.14

8.73

5.56

24.95

6.60

87.21

  1. SEER*Stat software (seer.cancer.gov/seerstat) was used to access the SEER data after signing research data agreement. All patients diagnosed with colon and rectal adenocarcinoma from 2006 to 2015 were included. A total of 179,323 CRC patients were included after screening